Last reviewed · How we verify

NCT01875783: DME FOUND

OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits

Completed NA Results posted Last updated 22 December 2017
What this trial tests

NA trial testing OCT imaging in Diabetes in 385 participants. Completed in 15 July 2016.

Timeline
17 March 2014
Primary endpoint
14 May 2015
15 July 2016

Quick facts

Lead sponsorJoslin Diabetes Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingdouble
Primary purposediagnostic
Enrollment385
Start date17 March 2014
Primary completion14 May 2015
Estimated completion15 July 2016
Sites4 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Joslin Diabetes Center — full company profile →

Who can join

18 and older, any sex, with Diabetes or Diabetic Macular Edema. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Rates of Retina Care Referral for Patients With Diabetic Macular Edema Primary · Baseline visit

Percentage of participants who are referred to a retina specialist for evaluation and management of DME after OCT imaging and OCT-guided referral algorithm

GroupValue95% CI
Retina Specialist Care44
Retinal Referral Rates for Patients With DME Secondary · Baseline visit

Count of eyes that are referred to a retina specialist for evaluation and management of DME after OCT imaging and OCT-guided referral algorithm

GroupValue95% CI
Eyes That Have Undergone OCT Imaging59
Rates of Retinal Treatment for Patients With DME Secondary · One month

Percentage of participants are referred by OCT-guided algorithm who are confirmed to have vision threatening retinopathy at first visit with retina specialist after study enrollment

GroupValue95% CI
Participants Referred for Retina Care14
Rates of Retinal Treatment Over 1 Year for Patients With DME Secondary · 9 months

Percentage of participants who are referred by OCT guided algorithm to a retina specialist who receive treatment for DME over the course of 9 months follow-up by retina specialist

GroupValue95% CI
Participants Referred for Retina Care18

Sponsor's own description

The purpose of this protocol is to determine whether point of care optical coherence tomography (OCT) imaging combined with an OCT-guided retinal referral algorithm at primary diabetes care visits increases rates of retina specialist eye care for patients with diabetic macular edema. The hypothesis is that OCT imaging with an automated OCT-guided referral algorithm will enable identification of patients at risk for vision loss from diabetic macular edema and facilitate direct referral to retina specialists for more timely evaluation and treatment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Retinal Telemedicine.
    Chee RI, Darwish D, Fernandez-Vega A, Patel S, et al · · 2018 · cited 18× · PMID 30140593 · DOI 10.1007/s40135-018-0161-8

Verify or expand the search:

Other trials of OCT imaging

Trials testing the same drug.

Other recruiting trials for Diabetes

Currently open trials in the same condition.

Other Joslin Diabetes Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01875783.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing